X4 Pharmaceuticals (XFOR) Form 3: Executive Chairman Reports No Holdings

Craig Adam R, serving as Executive Chairman and a Director of X4 Pharmaceuticals, Inc. (XFOR), filed an initial Form 3 dated 08/12/2025 reporting that he does not beneficially own any securities of the issuer.

Accepted by SEC EDGAR 08/14/2025 - 08:31 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Craig Adam R, serving as Executive Chairman and a Director of X4 Pharmaceuticals, Inc. (XFOR), filed an initial Form 3 dated 08/12/2025 reporting that he does not beneficially own any securities of the issuer. The filing includes an Exhibit 24 Power of Attorney and is signed on behalf of the reporting person by an attorney-in-fact on 08/14/2025.

Positive

• None.

Negative

• No securities beneficially owned reported by the Executive Chairman as of 08/12/2025

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the Form 3 filed for XFOR report?

The Form 3 filed for X4 Pharmaceuticals (XFOR) reports that Craig Adam R filed an initial ownership statement and does not beneficially own any securities of the issuer as of 08/12/2025.

What is Craig Adam R's role at X4 Pharmaceuticals (XFOR)?

The filing states he is the Executive Chairman and a Director of X4 Pharmaceuticals.

Was the Form 3 signed and are there exhibits?

Yes. The filing includes an Exhibit 24 Power of Attorney and is signed by an attorney-in-fact on 08/14/2025.

Does the Form 3 show any derivative or non-derivative holdings?

No. The filing explicitly states no securities are beneficially owned, and no entries appear in the non-derivative or derivative tables.

Was the Form 3 filed individually or jointly?

The form indicates it was filed by one reporting person (the reporting person checkbox is marked).

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Craig Adam R

(Last) (First) (Middle)

C/O X4 PHARMACEUTICALS INC.

61 NORTH BEACON STREET, 4TH FLOOR

(Street)

BOSTON MA 02134

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/12/2025

3. Issuer Name and Ticker or Trading Symbol
X4 Pharmaceuticals, Inc [ XFOR ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Chairman

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List: Exhibit 24 Power of Attorney

No securities are beneficially owned.

	/s/ David Kirske, Attorney-In-Fact	08/14/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.